Accumulatively, experimental investigations suggest RANKL signalling is deleterious to glucose homeostasis, with RANKL signalling increasing skeletal muscle [22] and hepatic [87, 88] insulin resistance, via NF-κB activation. The gene discussed is TNFSF11; the disease is Insulin resistance.